fluphenazine enanthate and fluphenazine

fluphenazine enanthate has been researched along with fluphenazine in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-199020 (74.07)18.7374
1990's0 (0.00)18.2507
2000's2 (7.41)29.6817
2010's4 (14.81)24.3611
2020's1 (3.70)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Goude, F; Lanza, JP; Lanza, M1
Domino, EF1
Assael, M; Guy, N; Raps, A1
Walton, R1
Rampertaap, MP2
Altamura, AC; Curry, SH; Montgomery, S; Wiles, DH1
Chouinard, G; Cohen, BM; Jones, B; Sommer, BR; Waternaux, C1
Annable, L; Chouinard, G; Ross-Chouinard, A1
Awad, AG; Hogan, TP1
Glazer, WM1
Kane, JM1
Domino, EF; Kovacic, B2
Bury, RG; Donaldson, GL1
Furukawa, T; Yamada, K1
POLLACK, SL; TOURLENTES, TT; ZOCCHI, AF1
BROOKS, GW; RAVARIS, CL; WEAVER, LA1
EBERT, AG; HESS, SM1
BARSA, JA; SAUNDERS, JC1
Braga, AL; Calixto, JB; Fachinetto, R; Ferreira, J; Paixão, MW; Pereira, RP; Puntel, RL; Rocha, JB; Villarinho, JG; Wagner, C1
Citrome, L; Jaffe, A; Levine, J1
Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T1
Athayde, ML; Boligon, AA; Busanello, A; Fachinetto, R; Leal, CQ; Reckziegel, P; Reis, EM; Röpke, J; Wagner, C1
Adams, CE; Asher, R; David, A; Eisenbruch, M; Jayaswal, A; Maayan, N; Quraishi, SN; Rathbone, J1
Imai, T; Nakada, Y; Ohura, K1

Reviews

4 review(s) available for fluphenazine enanthate and fluphenazine

ArticleYear
Neuroleptic malignant syndrome.
    Southern medical journal, 1986, Volume: 79, Issue:3

    Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors

1986
Depot fluphenazine: risk/benefit ratio.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5 Pt 2

    Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Patient Compliance; Psychotic Disorders; Receptors, Dopamine; Research Design; Risk; Schizophrenia; Schizophrenic Psychology

1984
The use of depot neuroleptics: clinical experience in the United States.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5 Pt 2

    Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Female; Fluphenazine; Humans; Male; Patient Readmission; Placebos; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; United States

1984
Fluphenazine decanoate (depot) and enanthate for schizophrenia.
    The Cochrane database of systematic reviews, 2015, Feb-05, Issue:2

    Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Injections, Intramuscular; Randomized Controlled Trials as Topic; Schizophrenia

2015

Trials

4 trial(s) available for fluphenazine enanthate and fluphenazine

ArticleYear
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.
    Psychopharmacology, 1985, Volume: 87, Issue:1

    Topics: Adult; Female; Fluphenazine; Humans; Male; Middle Aged; Prolactin; Schizophrenia

1985
Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    The American journal of psychiatry, 1982, Volume: 139, Issue:3

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Schizophrenic Psychology

1982
Depot fluphenazine: risk/benefit ratio.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5 Pt 2

    Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Patient Compliance; Psychotic Disorders; Receptors, Dopamine; Research Design; Risk; Schizophrenia; Schizophrenic Psychology

1984
The use of depot neuroleptics: clinical experience in the United States.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5 Pt 2

    Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Female; Fluphenazine; Humans; Male; Patient Readmission; Placebos; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; United States

1984

Other Studies

21 other study(ies) available for fluphenazine enanthate and fluphenazine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
[Effect of a single dose of some long-acting neuroleptics on the estrus cycle and the mammary gland of the rat].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1979, Volume: 173, Issue:4

    Topics: Animals; Antipsychotic Agents; Caproates; Estrus; Female; Flupenthixol; Fluphenazine; Mammary Glands, Animal; Organ Size; Ovary; Phenothiazines; Pregnancy; Pseudopregnancy; Rats; Thiazines; Uterus

1979
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Psychopharmacology. Supplementum, 1985, Volume: 2

    Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Macaca; Male; Motor Activity; Stereotyped Behavior; Substance Withdrawal Syndrome

1985
The Pisa syndrome during maintenance antipsychotic therapy.
    The American journal of psychiatry, 1986, Volume: 143, Issue:11

    Topics: Adult; Antipsychotic Agents; Dystonia; Female; Fluphenazine; Humans; Schizophrenia

1986
More than mere shots.
    The American journal of nursing, 1988, Volume: 88, Issue:5

    Topics: Chronic Disease; Communication; Fluphenazine; Haloperidol; Humans; Mental Disorders; Patient Care Team; Psychiatric Aides; Psychiatric Nursing

1988
Vitiligo-like syndrome following the use of fluphenazine enanthate.
    Missouri medicine, 1985, Volume: 82, Issue:1

    Topics: Adult; Female; Fluphenazine; Humans; Schizophrenia; Vitiligo

1985
Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Journal of clinical psychopharmacology, 1985, Volume: 5, Issue:6

    Topics: Delayed-Action Preparations; Fluphenazine; Humans; Regression Analysis; Schizophrenia

1985
Pharmacotherapy and suicide risk in schizophrenia.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1983, Volume: 28, Issue:4

    Topics: Adult; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Risk; Schizophrenia; Suicide

1983
Monkey models of tardive dyskinesia.
    Modern problems of pharmacopsychiatry, 1983, Volume: 21

    Topics: Animals; Benztropine; Biperiden; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Macaca; Male; Parasympatholytics; Species Specificity; Syndrome

1983
A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
    Journal of clinical psychopharmacology, 1982, Volume: 2, Issue:5

    Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Stress, Psychological; Time Factors

1982
Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy.
    Acta paediatrica Scandinavica, 1982, Volume: 71, Issue:2

    Topics: Abnormalities, Drug-Induced; Cleft Lip; Cleft Palate; Dicyclomine; Doxylamine; Female; Fluphenazine; Humans; Hypertelorism; Infant, Newborn; Male; Perineum; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pyridoxine; Schizophrenia, Disorganized

1982
Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
    Pharmacology, 1982, Volume: 24, Issue:3

    Topics: Aminooxyacetic Acid; Animals; Antiparkinson Agents; Catalepsy; Delayed-Action Preparations; Drug Synergism; Enkephalins; Fluphenazine; Haloperidol; Humans; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine

1982
CLINICAL TRIAL OF FLUPHENAZINE ENANTHATE-- A LONG-ACTING INJECTABLE TRANQUILIZER.
    The American journal of psychiatry, 1964, Volume: 121

    Topics: Biomedical Research; Fluphenazine; Humans; Hypnotics and Sedatives; Schizophrenia

1964
A CONTROLLED STUDY OF FLUPHENAZINE ENANTHATE IN CHRONIC SCHIZOPHRENIC PATIENTS.
    Diseases of the nervous system, 1965, Volume: 26

    Topics: Biomedical Research; Delayed-Action Preparations; Drug Therapy; Fluphenazine; Geriatrics; Humans; Injections; Injections, Subcutaneous; Research Design; Schizophrenia; Sesame Oil

1965
THE DISTRIBUTION AND METABOLISM OF FLUPHENAZINE ENANTHATE.
    The Journal of pharmacology and experimental therapeutics, 1965, Volume: 148

    Topics: Brain; Carbon Isotopes; Chromatography; Fluphenazine; Liver; Lung; Metabolism; Radiometry; Rats; Research

1965
A DOUBLE BLIND STUDY OF FLUPHENAZINE ENANTHATE.
    Diseases of the nervous system, 1965, Volume: 26

    Topics: Delayed-Action Preparations; Double-Blind Method; Drug Therapy; Fluphenazine; Geriatrics; Humans; Injections; Injections, Subcutaneous; Schizophrenia; Toxicology

1965
Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.
    Psychopharmacology, 2007, Volume: 194, Issue:3

    Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Benzene Derivatives; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Male; Mastication; Organoselenium Compounds; Oxidative Stress; Rats; Rats, Wistar

2007
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Schizophrenia research, 2010, Volume: 119, Issue:1-3

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

2010
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
    International clinical psychopharmacology, 2013, Volume: 28, Issue:5

    Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome

2013
Effect of Hypericum perforatum on different models of movement disorders in rats.
    Behavioural pharmacology, 2013, Volume: 24, Issue:7

    Topics: Animals; Disease Models, Animal; Fluphenazine; Hypericum; Male; Mastication; Motor Activity; Movement Disorders; Plant Extracts; Rats; Rats, Wistar; Reserpine

2013
Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection.
    Journal of pharmaceutical sciences, 2023, Volume: 112, Issue:7

    Topics: Butyrylcholinesterase; Decanoates; Fluphenazine; Heptanoates; Humans; Injections, Intramuscular; Prodrugs

2023